Schedule 13G ownership disclosure

REVANCE THERAPEUTICS INC

Common Stock, par value $0.001 per share · CUSIP: 761330109

Event date: 2024-12-31

Filing-level shares
5,686,631.0
Percent of class
5.4%
  • JPMORGAN CHASE & CO.

    Shares: 5,686,631.0 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000019617-25-000200
Form type
SCHEDULE 13G
Filer
JPMORGAN CHASE & CO
CIK
CIK 19617
Filed
Feb 11, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SCHEDULE 13G | SEC Filings Hub